We limit data available in the Overview Report for users who do not have Powerpack
Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Target Price Range
Recommendation Rating
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.86 | 21.55 | 30.25 | 31.66 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 45.98 | 31.07 | 37.85 | 65.73 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33,140 | 34,756 | 34,114 | 33,951 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.20 | 0.26 | 0.25 | 0.22 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,573.32 | 9,043.92 | 8,573.57 | 7,307.10 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74.31% | 63.14% | 64.95% | 66.99% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,948.96 | 1,629.51 | 1,751.58 | 1,951.86 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.65% | 18.02% | 20.43% | 26.71% | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,399.27 | 1,242.99 | 1,273.12 | 788.34 | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 189.89 | 216.57 | 202.29 | 902.32 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51.56 | 70.93 | 67.24 | 57.37 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 6.69 | 6.10 | 6.30 | 3.66 | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.30 | 30.04 | 0.68 | 19.25 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4.89) | (3.49) | (2.55) | (2.74) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.41 | 26.55 | (1.87) | 16.50 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 62.74 | 61.25 | 69.94 | 64.37 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 127.50 | 127.50 | 127.50 | 127.37 | — | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.12 | 5.12 | 5.00 | 17.38 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.47 | 0.39 | 0.47 | 1.11 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.38 | 0.45 | 0.45 | 0.99 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.10 | (0.17) | 0.33 | 0.75 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.08 | (0.18) | (11.92) | 2.60 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,312.85 | 3,830.62 | 87.18 | 2,451.79 | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (623.43) | (445.36) | (325.61) | (349.62) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 689.42 | 3,385.26 | (238.43) | 2,102.17 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,080.89 | 2,572.38 | 3,411.78 | 1,579.27 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,915.20 | 2,932.72 | 5,392.95 | 3,353.22 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2,413.86) | (5,027.21) | (1,175.87) | (2,630.06) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,999.51 | 7,809.95 | 8,916.86 | 8,199.13 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.92% | 0.94% | 0.94% | 0.55% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.81% | 36.60% | 14.14% | 21.91% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.98% | 8.28% | 8.02% | 4.82% | — | — | — |
ROE
|
Analyst Commentary (Summary)
Grupo Cibest S.A. - Sponsored ADR (CIB) Latest News
13 Aug
Grupo Cibest SA posted record ROE for Q2 2026 and raised full-year guidance. Record ROE and raised guidance signal stronger profitability and improved forward outlook.
11 Aug
Grupo Cibest S.A. released Q2 earnings call highlights covering financial results and operational updates. Q2 earnings updates affect financial performance outlook with moderate investor influence.
6 May
Grupo Cibest S.A. (CIB) released Q1 earnings call highlights covering financial results, operational updates, and forward guidance. Q1 earnings call highlights provide critical insights into financial performance and strategic outlook, significantly influencing CIB's stock trajectory and investor sentiment.
24 Feb
Grupo Cibest released highlights from its Q4 earnings call, detailing financial results, operational updates, and forward guidance. Q4 earnings call highlights affect quarterly financial performance and investor sentiment with moderate long-term implications.
2 Feb
Grupo Cibest S.A. - Sponsored ADR (CIB) is compared with ITT in terms of value investment potential. Key metrics such as price-to-earnings ratios, dividend yields, and growth prospects are analyzed to determine which stock offers better value for investors. The analysis highlights financial performance, market positioning, and future growth opportunities for both companies, ultimately guiding investors in making informed decisions. Comparative analysis of value metrics indicates a moderate influence on investment decisions.
30 Jan
Grupo Cibest S.A. - Sponsored ADR (CIB) has shown strong performance this year, outpacing its conglomerate peers in key metrics. Analysts are closely monitoring its growth trajectory and market positioning, highlighting factors contributing to its success. The company's strategic initiatives and market dynamics are expected to play a crucial role in its continued performance. Significant strategic moves and market dynamics are likely to alter the company's trajectory and investor sentiment.
23 Jan
Grupo Cibest S.A. - Sponsored ADR (CIB) has been upgraded to a 'Buy' rating by analysts, reflecting positive sentiment regarding the company's growth potential and market position. Factors contributing to this upgrade include strong financial performance, strategic initiatives, and favorable market conditions that are expected to enhance investor confidence. The upgrade suggests that analysts believe the stock is undervalued and presents a good investment opportunity moving forward. The upgrade to 'Buy' indicates significant positive sentiment and potential for improved market performance.
20 Jan
3M reported Q4 earnings that exceeded estimates, driven by a year-over-year increase in safety and industrial sales. The company's performance reflects a positive trend in these sectors, contributing to overall financial strength. The increase in safety and industrial sales may moderately influence 3M's financial performance and market positioning.
16 Jan
3M is preparing to report its Q4 earnings, with analysts anticipating insights into the company's financial performance and strategic direction. Investors are particularly focused on potential impacts from recent market dynamics and operational adjustments. The earnings report is expected to provide clarity on 3M's growth prospects and any challenges it may face moving forward. Earnings reports can moderately influence investor sentiment and financial performance, but the overall effect is expected to be balanced by other factors.
15 Jan
Grupo Cibest S.A. - Sponsored ADR (CIB) is compared with ITT in terms of value investment potential. The analysis highlights key financial metrics, growth prospects, and market positioning of both companies. Investors are encouraged to consider factors such as earnings growth, valuation ratios, and overall market conditions when making investment decisions. The comparison aims to guide value investors in selecting the more promising stock between CIB and ITT. The comparison of financial metrics and growth prospects indicates a moderately noticeable influence on investment decisions.
14 Jan
Grupo Cibest S.A. - Sponsored ADR (CIB) is reportedly outperforming other conglomerate stocks this year, raising questions about the broader market dynamics affecting these companies. Analysts are observing a divergence in performance, with CIB showing resilience and potential growth while other conglomerates lag behind. This trend may indicate a shift in investor sentiment and market positioning within the conglomerate sector. CIB's performance relative to other conglomerates suggests a moderately noticeable influence on its competitive positioning and market sentiment.
13 Jan
Viamericas has expanded its payment network to include Nequi, a digital financial platform, enhancing its service offerings for users. This integration allows customers to send and receive money through Nequi, facilitating easier transactions and access to financial services. The partnership aims to improve user experience and broaden the reach of Viamericas' payment solutions in the digital finance sector. The expansion into Nequi is expected to moderately influence Viamericas' competitive positioning and user engagement in the digital payment landscape.
8 Jan
Grupo Cibest S.A. - Sponsored ADR (CIB) is highlighted among top stocks with solid shareholder yield in the current macroeconomic environment. The article emphasizes the importance of shareholder yield as a key metric for investors, particularly in times of economic uncertainty. CIB's strong performance and commitment to returning value to shareholders through dividends and buybacks position it favorably in the market. CIB's shareholder yield indicates a moderately noticeable influence on its financial performance and market sentiment.
7 Jan
Grupo Cibest S.A. - Sponsored ADR (CIB) is highlighted among four diversified operations stocks to monitor despite facing industry challenges. The company is noted for its resilience and potential for growth in a fluctuating market, making it a noteworthy consideration for investors looking for stability in diversified sectors. Moderate influence is expected due to the company's diversified operations amidst industry headwinds.
30 Dec
Grupo Cibest S.A. - Sponsored ADR (CIB) is being compared to ITT in terms of value stock potential. Analysts are evaluating financial metrics, market conditions, and growth prospects to determine which stock offers better value for investors. Key factors include earnings performance, market trends, and competitive positioning. Comparative analysis of CIB and ITT indicates moderate influence on investor sentiment and market performance.
23 Dec
Grupo Cibest S.A. - Sponsored ADR (CIB) has shown strong performance this year, outpacing its conglomerate peers. The stock's growth can be attributed to strategic initiatives and market positioning that have resonated well with investors. Analysts are optimistic about the company's future prospects, suggesting that its competitive advantages may continue to drive positive results in the coming months. Significant strategic initiatives and market positioning are likely to alter the company's trajectory and investor sentiment.
12 Dec
Grupo Cibest S.A. - Sponsored ADR (CIB) is being compared to Honeywell International Inc. (HON) to determine which stock presents a better value option for investors. The analysis includes financial metrics, market performance, and growth potential of both companies, highlighting key differences that may influence investment decisions. Comparative analysis of CIB and HON indicates moderate influence on investor sentiment and market positioning.
3 Dec
Grupo Cibest S.A. - Sponsored ADR (CIB) is highlighted as a strong momentum pick due to its recent performance and growth potential. Analysts suggest that the company's strategic initiatives and market positioning make it an attractive investment opportunity. Positive trends in financial metrics and market sentiment further support this outlook, indicating that CIB could outperform its peers in the near future. Significant strategic initiatives and positive market trends are expected to influence the company's future performance.
26 Nov
Grupo Cibest S.A. - Sponsored ADR (CIB) is being compared to Honeywell International Inc. (HON) to determine which stock offers better value at present. Analysts are evaluating financial metrics, market performance, and growth potential of both companies to guide investors in making informed decisions. The analysis includes price-to-earnings ratios, dividend yields, and overall market sentiment towards each stock. Comparative analysis of value stocks can moderately influence investor sentiment and market positioning.
Grupo Cibest S.A. - Sponsored ADR (CIB) has been underperforming compared to other conglomerate stocks this year, raising questions about its market position and future growth potential. Analysts are examining the factors contributing to this lag, including market dynamics and competitive pressures that may be affecting CIB's performance relative to its peers. CIB's underperformance relative to conglomerates suggests moderate influence on its financial performance and market sentiment.
24 Nov
Grupo Cibest S.A. - Sponsored ADR (CIB) has been highlighted as one of the best momentum stocks to buy for November 24, indicating strong performance and positive market sentiment surrounding the company. Investors are encouraged to consider CIB for potential gains based on its recent momentum. CIB's recognition as a momentum stock suggests a moderately noticeable influence on its market performance.
Grupo Cibest S.A. - Sponsored ADR (CIB) is highlighted among new strong buy stocks for November 24, indicating positive market sentiment and potential investment opportunities. The inclusion suggests confidence in the company's future performance and growth prospects. Inclusion as a strong buy stock indicates moderate positive sentiment that may influence investor interest and market performance.
Grupo Cibest S.A. - Sponsored ADR (CIB) has been highlighted as one of the best value stocks to consider for investment on November 24. The company is noted for its strong fundamentals and potential for growth, making it an attractive option for investors seeking value opportunities in the current market environment. The company's strong fundamentals suggest a moderately noticeable influence on its financial performance and market positioning.
Grupo Cibest S.A. - Sponsored ADR (CIB) has been highlighted as one of the best income stocks to consider for investment on November 24. The company is recognized for its strong dividend yield and potential for stable returns, making it an attractive option for income-focused investors. Analysts suggest that CIB's financial health and market position could provide favorable outcomes in the current economic climate. CIB's strong dividend yield and financial health may moderately influence its market performance and investor sentiment.
10 Nov
Grupo Cibest S.A. - Sponsored ADR (CIB) has been upgraded to a Strong Buy rating by analysts, reflecting positive sentiment regarding the company's growth potential and market position. Factors contributing to this upgrade include strong financial performance, strategic initiatives, and favorable market conditions that are expected to enhance investor confidence. The upgrade signals a shift in outlook, suggesting that CIB is well-positioned for future success. The upgrade to Strong Buy indicates significant positive sentiment and potential for enhanced market performance.
Grupo Cibest S.A. - Sponsored ADR (CIB) has been highlighted as one of the best growth stocks to consider for investment as of November 10. The company is recognized for its strong performance metrics and growth potential, making it an attractive option for investors looking to capitalize on emerging opportunities in the market. The identification of Grupo Cibest S.A. as a top growth stock suggests significant potential for future performance and investor interest.
Grupo Cibest S.A. - Sponsored ADR (CIB) is being compared to FSS to determine which stock presents a better value option for investors. The analysis considers various financial metrics and market conditions affecting both companies, aiming to provide insights into their potential for growth and investment appeal. Key factors include valuation ratios, earnings performance, and market sentiment, which are critical in assessing the attractiveness of CIB relative to FSS. The comparison of CIB with FSS highlights relevant financial metrics that could moderately influence investor sentiment and market positioning.
Grupo Cibest S.A. - Sponsored ADR (CIB) has shown notable performance this year, outpacing its peers in the conglomerate sector. Analysts are evaluating the company's growth trajectory and market positioning, highlighting its competitive advantages and strategic initiatives. The stock's performance reflects broader market trends and investor sentiment towards conglomerates, indicating a potential shift in market dynamics. CIB's performance relative to peers suggests a moderately noticeable influence on its competitive positioning and market sentiment.
6 Nov
Grupo Cibest S.A. - Sponsored ADR (CIB) has been highlighted as one of the best growth stocks to consider for investment as of November 6. The company is recognized for its strong performance metrics and potential for future growth, making it an attractive option for investors looking to capitalize on emerging opportunities in the market. The company's strong performance metrics and growth potential indicate a significant impact on its future and market performance.
5 Nov
Grupo Cibest S.A. is set to report its Q3 earnings soon, with analysts anticipating insights into the company's financial performance and strategic direction. Investors are keen to understand how recent market trends and operational changes may influence the results. The upcoming earnings report is expected to provide crucial information that could impact investor sentiment and the company's stock performance. The earnings report is likely to affect key areas of financial performance and market sentiment, but the overall impact is expected to be somewhat limited.
Grupo Financiero Bancolombia (CIB), Colombia’s largest bank by assets, has shown impressive resilience through a decade of macroeconomic storms—from the 2016 FARC peace accord optimism, COVID shocks, inflation peaks, to recent rate stabilization. Revenue grew at a 5.2% CAGR to $8.57 billion in 2024, with a 38% surge in 2023 fueled by high interest rates expanding net interest margins, though it dipped 5% last year amid slowing growth. Profitability roared back post-pandemic, with EPS leaping from $0.31 in 2020 to $6.30 in 2024, supported by operational efficiency (revenue per employee ~$251k) and a fortress balance sheet: equity up 32% to $8.92 billion, debt halved to $5.39 billion yielding net cash, and ROE steady at 8.0%—modest but reliable for an emerging market lender.
Yet, caution flags abound: gross margins compressed to 64.9% on rising credit risks, 2024 free cash flow swung negative at -$238 million after strong prior years, and valuations scream deep value (PE 5x, PS 0.47x, PB 0.45x) but with the stock at recent highs aligning to analyst high targets—implying 16% downside to consensus means. No insider buying tempers enthusiasm amid Colombia’s fiscal strains and reform risks.
This setup warrants watchful optimism: hold core positions, layer in on dips, as net cash buffers downside while catalysts like rate cuts and digital ramps loom. Fundamentals at highs versus decade-low multiples signal potential, but macro headwinds like sluggish GDP and oil volatility demand prudence—read the full analysis for the balanced risks and steady performer verdict.